Logo image of MNKD

MANNKIND CORP (MNKD) Stock Fundamental Analysis

USA - NASDAQ:MNKD - US56400P7069 - Common Stock

5.55 USD
+0.01 (+0.18%)
Last: 10/30/2025, 8:26:12 PM
5.56 USD
+0.01 (+0.18%)
After Hours: 10/30/2025, 8:26:12 PM
Fundamental Rating

5

Taking everything into account, MNKD scores 5 out of 10 in our fundamental rating. MNKD was compared to 534 industry peers in the Biotechnology industry. MNKD has only an average score on both its financial health and profitability. MNKD is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one!


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

In the past year MNKD was profitable.
In the past year MNKD had a positive cash flow from operations.
MNKD had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: MNKD reported negative operating cash flow in multiple years.
MNKD Yearly Net Income VS EBIT VS OCF VS FCFMNKD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M -300M

1.2 Ratios

Looking at the Return On Assets, with a value of 7.85%, MNKD belongs to the top of the industry, outperforming 92.51% of the companies in the same industry.
MNKD's Return On Invested Capital of 21.43% is amongst the best of the industry. MNKD outperforms 97.57% of its industry peers.
Industry RankSector Rank
ROA 7.85%
ROE N/A
ROIC 21.43%
ROA(3y)-8.37%
ROA(5y)-20.59%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MNKD Yearly ROA, ROE, ROICMNKD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200

1.3 Margins

With an excellent Profit Margin value of 10.71%, MNKD belongs to the best of the industry, outperforming 92.32% of the companies in the same industry.
MNKD has a Operating Margin of 26.40%. This is amongst the best in the industry. MNKD outperforms 95.69% of its industry peers.
The Gross Margin of MNKD (77.36%) is better than 83.90% of its industry peers.
MNKD's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 26.4%
PM (TTM) 10.71%
GM 77.36%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y13.44%
GM growth 5Y5.99%
MNKD Yearly Profit, Operating, Gross MarginsMNKD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800 -1K

More info and screens

4

2. Health

2.1 Basic Checks

MNKD has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for MNKD has been increased compared to 1 year ago.
MNKD has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, MNKD has an improved debt to assets ratio.
MNKD Yearly Shares OutstandingMNKD Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
MNKD Yearly Total Debt VS Total AssetsMNKD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

MNKD has an Altman-Z score of -6.80. This is a bad value and indicates that MNKD is not financially healthy and even has some risk of bankruptcy.
MNKD has a worse Altman-Z score (-6.80) than 66.85% of its industry peers.
The Debt to FCF ratio of MNKD is 10.09, which is on the high side as it means it would take MNKD, 10.09 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 10.09, MNKD belongs to the top of the industry, outperforming 91.57% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 10.09
Altman-Z -6.8
ROIC/WACC2.6
WACC8.25%
MNKD Yearly LT Debt VS Equity VS FCFMNKD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

2.3 Liquidity

A Current Ratio of 2.50 indicates that MNKD has no problem at all paying its short term obligations.
MNKD has a Current ratio of 2.50. This is in the lower half of the industry: MNKD underperforms 68.91% of its industry peers.
MNKD has a Quick Ratio of 2.24. This indicates that MNKD is financially healthy and has no problem in meeting its short term obligations.
MNKD's Quick ratio of 2.24 is on the low side compared to the rest of the industry. MNKD is outperformed by 69.85% of its industry peers.
Industry RankSector Rank
Current Ratio 2.5
Quick Ratio 2.24
MNKD Yearly Current Assets VS Current LiabilitesMNKD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

7

3. Growth

3.1 Past

MNKD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 125.00%, which is quite impressive.
Looking at the last year, MNKD shows a very strong growth in Revenue. The Revenue has grown by 21.46%.
MNKD shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 35.29% yearly.
EPS 1Y (TTM)125%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)21.46%
Revenue growth 3Y55.86%
Revenue growth 5Y35.29%
Sales Q2Q%5.72%

3.2 Future

MNKD is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 43.96% yearly.
Based on estimates for the next years, MNKD will show a quite strong growth in Revenue. The Revenue will grow by 14.31% on average per year.
EPS Next Y18.4%
EPS Next 2Y5.62%
EPS Next 3Y32.25%
EPS Next 5Y43.96%
Revenue Next Year14.19%
Revenue Next 2Y16.74%
Revenue Next 3Y15.12%
Revenue Next 5Y14.31%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
MNKD Yearly Revenue VS EstimatesMNKD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 200M 400M 600M 800M
MNKD Yearly EPS VS EstimatesMNKD Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -1 -2

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

MNKD is valuated quite expensively with a Price/Earnings ratio of 61.67.
Compared to the rest of the industry, the Price/Earnings ratio of MNKD indicates a rather cheap valuation: MNKD is cheaper than 91.57% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.19, MNKD is valued quite expensively.
MNKD is valuated quite expensively with a Price/Forward Earnings ratio of 62.18.
Based on the Price/Forward Earnings ratio, MNKD is valued cheaply inside the industry as 88.58% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of MNKD to the average of the S&P500 Index (22.50), we can say MNKD is valued expensively.
Industry RankSector Rank
PE 61.67
Fwd PE 62.18
MNKD Price Earnings VS Forward Price EarningsMNKD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

MNKD's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. MNKD is cheaper than 94.01% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, MNKD is valued cheaply inside the industry as 92.32% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 59.15
EV/EBITDA 18.76
MNKD Per share dataMNKD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 0.6 0.8

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as MNKD's earnings are expected to grow with 32.25% in the coming years.
PEG (NY)3.35
PEG (5Y)N/A
EPS Next 2Y5.62%
EPS Next 3Y32.25%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MNKD!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MANNKIND CORP

NASDAQ:MNKD (10/30/2025, 8:26:12 PM)

After market: 5.56 +0.01 (+0.18%)

5.55

+0.01 (+0.18%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)08-06 2025-08-06/bmo
Earnings (Next)11-11 2025-11-11/amc
Inst Owners55.89%
Inst Owner Change0.53%
Ins Owners1.51%
Ins Owner Change2.5%
Market Cap1.70B
Revenue(TTM)301.74M
Net Income(TTM)32.32M
Analysts84.62
Price Target10.78 (94.23%)
Short Float %8.34%
Short Ratio5.14
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-55.44%
Min EPS beat(2)-100%
Max EPS beat(2)-10.87%
EPS beat(4)0
Avg EPS beat(4)-40.95%
Min EPS beat(4)-100%
Max EPS beat(4)-10.87%
EPS beat(8)2
Avg EPS beat(8)-37.57%
EPS beat(12)5
Avg EPS beat(12)-17.45%
EPS beat(16)6
Avg EPS beat(16)-13.49%
Revenue beat(2)1
Avg Revenue beat(2)-1.82%
Min Revenue beat(2)-4.55%
Max Revenue beat(2)0.9%
Revenue beat(4)2
Avg Revenue beat(4)-2.76%
Min Revenue beat(4)-7.78%
Max Revenue beat(4)0.9%
Revenue beat(8)5
Avg Revenue beat(8)1.49%
Revenue beat(12)8
Avg Revenue beat(12)4.61%
Revenue beat(16)11
Avg Revenue beat(16)4.15%
PT rev (1m)0%
PT rev (3m)12.76%
EPS NQ rev (1m)-24.99%
EPS NQ rev (3m)-52.38%
EPS NY rev (1m)-12.16%
EPS NY rev (3m)-48.89%
Revenue NQ rev (1m)-3.95%
Revenue NQ rev (3m)0.59%
Revenue NY rev (1m)-1.35%
Revenue NY rev (3m)0.94%
Valuation
Industry RankSector Rank
PE 61.67
Fwd PE 62.18
P/S 5.64
P/FCF 59.15
P/OCF 49.29
P/B N/A
P/tB N/A
EV/EBITDA 18.76
EPS(TTM)0.09
EY1.62%
EPS(NY)0.09
Fwd EY1.61%
FCF(TTM)0.09
FCFY1.69%
OCF(TTM)0.11
OCFY2.03%
SpS0.98
BVpS-0.18
TBVpS-0.2
PEG (NY)3.35
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 7.85%
ROE N/A
ROCE 26.57%
ROIC 21.43%
ROICexc 45.85%
ROICexgc 48.02%
OM 26.4%
PM (TTM) 10.71%
GM 77.36%
FCFM 9.54%
ROA(3y)-8.37%
ROA(5y)-20.59%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y13.44%
GM growth 5Y5.99%
F-Score8
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 10.09
Debt/EBITDA 3.03
Cap/Depr 67.99%
Cap/Sales 1.91%
Interest Coverage 5.4
Cash Conversion 39.2%
Profit Quality 89.07%
Current Ratio 2.5
Quick Ratio 2.24
Altman-Z -6.8
F-Score8
WACC8.25%
ROIC/WACC2.6
Cap/Depr(3y)397.13%
Cap/Depr(5y)337.1%
Cap/Sales(3y)10.78%
Cap/Sales(5y)10.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)125%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
EPS Next Y18.4%
EPS Next 2Y5.62%
EPS Next 3Y32.25%
EPS Next 5Y43.96%
Revenue 1Y (TTM)21.46%
Revenue growth 3Y55.86%
Revenue growth 5Y35.29%
Sales Q2Q%5.72%
Revenue Next Year14.19%
Revenue Next 2Y16.74%
Revenue Next 3Y15.12%
Revenue Next 5Y14.31%
EBIT growth 1Y74.55%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y150.29%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y229.39%
OCF growth 3YN/A
OCF growth 5YN/A

MANNKIND CORP / MNKD FAQ

What is the fundamental rating for MNKD stock?

ChartMill assigns a fundamental rating of 5 / 10 to MNKD.


What is the valuation status for MNKD stock?

ChartMill assigns a valuation rating of 5 / 10 to MANNKIND CORP (MNKD). This can be considered as Fairly Valued.


Can you provide the profitability details for MANNKIND CORP?

MANNKIND CORP (MNKD) has a profitability rating of 5 / 10.


Can you provide the expected EPS growth for MNKD stock?

The Earnings per Share (EPS) of MANNKIND CORP (MNKD) is expected to grow by 18.4% in the next year.